Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Baretton

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Der Urologe. Ausg. A|July 13, 2007
[Comparative evaluation of expression patterns of established and new prostate carcinoma associated genes with reference to suitability for molecular biologic diagnostic and prognostic factors]S Füssel, S Unversucht, A Meye, et al.
The Journal of Infectious Diseases|March 23, 2001
Hepatitis C virus-specific CD4+ T cell response after liver transplantation occurs early, is multispecific, compartmentalizes to the liver, and does not correlate with recurrent diseaseC A Schirren, M C Jung, T Worzfeld, et al.
International Journal of Oncology|May 10, 2007
Are overexpressed alternative survivin transcripts in human bladder cancer suitable targets for siRNA-mediated in vitro inhibition?D Wuttig, D Kunze, S Fuessel, et al.
Der Pathologe|July 5, 2016
[HER2 testing in gastric cancer : Results of a meeting of German experts]G Baretton, M Dietel, T Gaiser, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 12, 2002
Tissue factor deficiency causes cardiac fibrosis and left ventricular dysfunctionR Pawlinski, A Fernandes, B Kehrle, et al.
The British Journal of Dermatology|June 29, 2021
High tumour mutational burden and EGFR/MAPK pathway activation are therapeutic targets in metastatic porocarcinomaD Westphal, M Garzarolli, M Sergon, et al.
Virchows Archiv : an International Journal of Pathology|January 28, 2018
Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnosticsB Hirsch, V Endris, S Lassmann, et al.
ESMO Open|November 22, 2021
Rationale and design of the CRAFT (Continuous ReAssessment with Flexible ExTension in Rare Malignancies) multicenter phase II trialC E Heilig, P Horak, S Kreutzfeldt, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
17.6% of patients in a German cohort with exocrine pancreatic cancer were diagnosed with a genetic tumor syndrome-a case for universal genetic testing?D William, M Bermúdez, A Kübler, et al.
Zeitschrift Fur Gastroenterologie|April 9, 2011
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]M Moehler, S-E Al-Batran, T Andus, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Der Urologe. Ausg. A|July 13, 2007
[Comparative evaluation of expression patterns of established and new prostate carcinoma associated genes with reference to suitability for molecular biologic diagnostic and prognostic factors]S Füssel, S Unversucht, A Meye, et al.
The Journal of Infectious Diseases|March 23, 2001
Hepatitis C virus-specific CD4+ T cell response after liver transplantation occurs early, is multispecific, compartmentalizes to the liver, and does not correlate with recurrent diseaseC A Schirren, M C Jung, T Worzfeld, et al.
International Journal of Oncology|May 10, 2007
Are overexpressed alternative survivin transcripts in human bladder cancer suitable targets for siRNA-mediated in vitro inhibition?D Wuttig, D Kunze, S Fuessel, et al.
Der Pathologe|July 5, 2016
[HER2 testing in gastric cancer : Results of a meeting of German experts]G Baretton, M Dietel, T Gaiser, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 12, 2002
Tissue factor deficiency causes cardiac fibrosis and left ventricular dysfunctionR Pawlinski, A Fernandes, B Kehrle, et al.
The British Journal of Dermatology|June 29, 2021
High tumour mutational burden and EGFR/MAPK pathway activation are therapeutic targets in metastatic porocarcinomaD Westphal, M Garzarolli, M Sergon, et al.
Virchows Archiv : an International Journal of Pathology|January 28, 2018
Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnosticsB Hirsch, V Endris, S Lassmann, et al.
ESMO Open|November 22, 2021
Rationale and design of the CRAFT (Continuous ReAssessment with Flexible ExTension in Rare Malignancies) multicenter phase II trialC E Heilig, P Horak, S Kreutzfeldt, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
17.6% of patients in a German cohort with exocrine pancreatic cancer were diagnosed with a genetic tumor syndrome-a case for universal genetic testing?D William, M Bermúdez, A Kübler, et al.
Zeitschrift Fur Gastroenterologie|April 9, 2011
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]M Moehler, S-E Al-Batran, T Andus, et al.
Pageof 9